Product NDC: | 45567-0555 |
Proprietary Name: | Kit for the Preparation of Technetium Tc99m Sestamibi |
Non Proprietary Name: | Kit for the Preparation of Technetium Tc99m Sestamibi |
Active Ingredient(s): | 1 mg/10mL & nbsp; Kit for the Preparation of Technetium Tc99m Sestamibi |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45567-0555 |
Labeler Name: | Pharmalucence, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079157 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090710 |
Package NDC: | 45567-0555-2 |
Package Description: | 30 VIAL in 1 KIT (45567-0555-2) > 10 mL in 1 VIAL |
NDC Code | 45567-0555-2 |
Proprietary Name | Kit for the Preparation of Technetium Tc99m Sestamibi |
Package Description | 30 VIAL in 1 KIT (45567-0555-2) > 10 mL in 1 VIAL |
Product NDC | 45567-0555 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Kit for the Preparation of Technetium Tc99m Sestamibi |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090710 |
Marketing Category Name | ANDA |
Labeler Name | Pharmalucence, Inc. |
Substance Name | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
Strength Number | 1 |
Strength Unit | mg/10mL |
Pharmaceutical Classes |